Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

15 Oct 2015

Abstract excerpt

UNLABELLED: The epitopes defined by HIV-1 broadly neutralizing antibodies (bNAbs) are valuable templates for vaccine design, and studies of the immunological development of these antibodies are providing insights for vaccination strategies. In addition, the most potent and broadly reactive of these bNAbs have potential for clinical use. We previously described a family of 12 V1V2-directed neutralizing antibodies,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Research and Treatment
Share to Immunotherapy and Immune Responses
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26468542
DOI: 10.1128/jvi.01791-15

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional PotencyPMID 26468542Read ↗

Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop.Semantic proximity Read ↗

Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding SiteSemantic proximity Read ↗

Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.Semantic proximity Read ↗

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibodySemantic proximity Read ↗

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.Semantic proximity Read ↗

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half lifeSemantic proximity Read ↗

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half lifeSemantic proximity Read ↗

Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and ImmunotypesSemantic proximity Read ↗

Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex.Semantic proximity Read ↗

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesSemantic proximity Read ↗

V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC ActivitySemantic proximity Read ↗

Identification of a novel broadly HIV-1-neutralizing antibody from a CRF01_AE-infected Chinese donorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.